Skip to main content
All lobbying filings

MILLER STRATEGIES, LLC

MILLER STRATEGIES, LLC filed a Q2 report for GRAIL LLC on July 20, 2026, reporting $60,000 in lobbying income.

Lobbying for GRAIL LLC · Biotechnology company

All filings by MILLER STRATEGIES, LLC · Everything GRAIL LLC has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 20, 2026
Income
$60,000
What the client paid this registrant for the period.
Client based in
California

Official filing document

 Government bodies contacted 1

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2
Health Issues

Healthcare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening; including H.R.842 - The Nancy Gardner Sewell Multi-Cancer Early Detection Screening Coverage Act; S.339 - The Nancy Gardner Sewell Multi-Cancer Early Detection Screening Coverage Act

Medicare/Medicaid

Medicare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening; including H.R.842 - The Nancy Gardner Sewell Multi-Cancer Early Detection Screening Coverage Act; S.339 - The Nancy Gardner Sewell Multi-Cancer Early Detection Screening Coverage Act

 Bills named in this filing 2
  • H.R. 842
    Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
  • S. 339
    Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem